Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $48.5M | $114.7M | $0 | $0 | — | — | — | — | — |
| Research & development | $174.1M | $138.5M | $135.3M | $170.9M | $170.3M | $160.9M | $143.4M | $55.3M | $891,000 |
| Operating expenses | $219.2M | $174.6M | $183.8M | $218.6M | $216.1M | $234.0M | $186.1M | $149.0M | $6.7M |
| Operating income | −$170.7M | −$59.9M | −$183.8M | −$218.6M | −$216.1M | −$234.0M | −$186.1M | −$149.0M | −$6.7M |
| Operating margin | −352.23% | −52.24% | — | — | — | — | — | — | — |
| EBITDA | −$170.7M | −$59.1M | −$182.2M | −$216.8M | −$214.4M | −$232.6M | −$185.2M | −$148.7M | −$6.7M |
| EBITDA margin | −352.18% | −51.51% | — | — | — | — | — | — | — |
| Net income | −$170.4M | −$56.5M | −$179.8M | −$229.4M | −$234.0M | −$243.4M | −$180.3M | −$147.0M | −$6.8M |
| Net profit margin | −351.49% | −49.28% | — | — | — | — | — | — | — |
| Basic EPSper basic share | -$0.75 | -$0.25 | -$1.18 | -$2.71 | -$3.13 | -$3.55 | -$3.29 | -$22.59 | -$0.74 |
| Diluted EPSper diluted share | -$0.75 | -$0.25 | -$1.18 | -$2.71 | -$3.13 | -$3.55 | -$3.29 | -$22.59 | -$0.74 |
Reported shareholders
| Holder | % owned |
|---|---|
D. E. Shaw & Co., Inc. | 8.38%40.96M shares |
683 Capital Management, LLC | 8.02%39.2M shares |
DeepCurrents Investment Group LLC | 7.70%37.67M shares |
Context Capital Management, LLC | 5.92%28.95M shares |
Worth Venture Partners, LLC | 5.12%25.02M shares |
Kalehua Capital Management LLC | 4.56%22.3M shares |
AQR CAPITAL MANAGEMENT LLC | 3.20%15.63M shares |
GSA CAPITAL PARTNERS LLP | 3.07%14.99M shares |
WOLVERINE ASSET MANAGEMENT LLC | 2.64%12.89M shares |
RENAISSANCE TECHNOLOGIES LLC | 2.38%11.63M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 1.93%9.42M shares |
ARCH Venture Management, LLC | 1.65%8.06M shares |
BARCLAYS PLC | 1.60%7.83M shares |
Octagon Capital Advisors LP | 1.59%7.75M shares |
BlackRock, Inc. | 1.57%7.67M shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.55%7.57M shares |
TWO SIGMA INVESTMENTS, LP | 1.52%7.43M shares |
SAMSARA BIOCAPITAL, LLC | 1.48%7.22M shares |
Qube Research & Technologies Ltd | 1.45%7.07M shares |
Hasnain Faheem | ≈1.28%6.25M shares |
Percentages use 488.85M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 19, 2025Form 4 | Milligan SandraDirector | BuyCommon Stock | 26.1K | $1.92 | $50.0K | 58.0K |